Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
243 studies found for:    Ankylosing Spondylitis

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
Ankylosing Spondylitis
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results 		A Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Biological: adalimumab
2 Completed Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis
Conditions: Ankylosing Spondylitis;   Psoriatic Arthritis
Intervention:
3 Completed
Has Results 		Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: adalimumab (D2E7);   Biological: placebo
4 Completed
Has Results 		Study Evaluating Etanercept for the Treatment of Active, Severe, and Advanced Axial Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: Etanercept (Enbrel);   Other: Placebo
5 Completed
Has Results 		Study Evaluating Etanercept in Subjects With Ankylosing Spondylitis in Spain
Condition: Ankylosing Spondylitis
Interventions: Drug: etanercept;   Drug: etanercept/placebo
6 Active, not recruiting Impact of Adalimumab (Humira) Therapy on Selected Health Care Resource Utilization and Sick Leave in Patients With Ankylosing Spondylitis in Clinical Practice
Condition: Ankylosing Spondylitis
Intervention:
7 Completed Safety and Effectiveness of Adalimumab (Humira) in Patients With Ankylosing Spondylitis in Clinical Routine
Condition: Ankylosing Spondylitis
Intervention:
8 Completed
Has Results 		Study Evaluating Etanercept and Sulphasalazine in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: etanercept;   Drug: sulphasalazine (SSZ)
9 Completed
Has Results 		Work Productivity in Active Ankylosing Spondylitis (AS) Patients Treated With Enbrel.
Condition: Ankylosing Spondylitis
Intervention: Drug: Enbrel
10 Recruiting Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: Tofacitinib 2 mg;   Drug: Tofacitinib 5 mg;   Drug: Tofacitinib 10 mg;   Drug: Placebo
11 Completed
Has Results 		Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: adalimumab (D2E7);   Biological: placebo
12 Recruiting Observe the Frequency of Extra-Axial Symptoms in Korean Ankylosing Spondylitis (AS) Patients
Condition: Ankylosing Spondylitis
Intervention:
13 Recruiting Phase II Clinical Study of Thalidomide in the Treatment of Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: Thalidomide 150mg;   Drug: Thalidomide 100mg;   Drug: Placebo
14 Completed
Has Results 		Study of the Safety and Efficacy of Golimumab in Chinese Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: Placebo;   Drug: Golimumab;   Drug: Golimumab (placebo group)
15 Recruiting A Study of Golimumab in Participants With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: Placebo;   Drug: Golimumab
16 Completed
Has Results 		Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: adalimumab;   Other: placebo
17 Completed Efficacy of AIN457 in Adults (18-65 Years) With Moderate to Severe Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: AIN457;   Drug: ARIN457
18 Completed
Has Results 		Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) After Unsustainable Response to Biologicals and Disease Modifying Antirheumatic Drugs
Conditions: Rheumatoid Arthritis;   Ankylosing Spondylitis;   Psoriatic Arthritis
Intervention:
19 Unknown † European Ankylosing Spondylitis Infliximab Cohort (EASIC) Follow up Registration Study
Condition: Ankylosing Spondylitis
Intervention:
20 Recruiting Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)
Condition: Ankylosing Spondylitis
Intervention:
To Top

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
† Indicates status has not been verified in more than two years